Optionale Produktanalyse
Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
Chevron Corporation's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $409.2B | |
|---|---|---|
| Revenue (ttm) | 209.4B | |
| Net income (ttm) | 20.6B | |
| EPS (ttm) | $10.4 | |
| Shares out | 2B | |
| P/E (trailing) | 22.0x | |
| P/E (forward) | 15.8x | |
| Dividend | $7.12 (3.11%) | |
| Volume | 4,943,111 | |
| Beta | 0.52 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $155.61B | $235.72B | $196.91B | $193.41B | $184.43B | +4.3% |
| Gross profit | $45.43B | $73.98B | $60.39B | $56.93B | $56.09B | +5.4% |
| Operating income | $22.35B | $50.19B | $30.05B | $28.10B | $20.96B | -1.6% |
| Net income | $15.63B | $35.47B | $21.37B | $17.66B | $12.30B | -5.8% |
| EPS (diluted) | $8.14 | $18.28 | $11.36 | $9.72 | $6.63 | -5.0% |
| EBITDA | $39.36B | $66.49B | $47.82B | $45.81B | $41.42B | +1.3% |
| R&D | $268.0M | $268.0M | $320.0M | $353.0M | $427.0M | +12.4% |
| SG&A | $4.01B | $4.31B | $4.14B | $4.83B | $5.13B | +6.3% |
Recent company headlines from major financial publishers.
This remains the central path because later estimate increases improve the level but do not remove the FY2027 reversal. Non-contracting FY2027 revenue would disconfirm it.
Upward revisions would need to broaden beyond the near-term rebound. The case fades if earnings weaken or recurring investment absorbs more operating cash.
| Ke ↓ / g → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 4.9% | $202 | $216 | $235 | $264 | $309 |
| 5.9% | $174 | $182 | $192 | $206 | $224 |
| 6.9% | $155 | $160 | $170 | $174 | $183 |
| 7.9% | $141 | $144 | $148 | $153 | $159 |
| 8.9% | $129 | $132 | $135 | $138 | $142 |
Upcoming earnings date and setup when available.
Das Rating, das die veröffentlichte Research-Ausgabe des jeweiligen Monats trug. Ein Rating vergleicht den Kurs zum Analysezeitpunkt mit dem Fair Value; es ist kein Nachweis, ob die Einschätzung zutraf.
| Jahr | Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
